CARYSIL
|
CARYSIL Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 21.59 | 19.58 | 24.26 | 14.66 | 8.27 |
| CEPS(Rs) | 33.86 | 29.58 | 31.08 | 19.47 | 13.03 |
| DPS(Rs) | 2.00 | 2.00 | 2.40 | 2.00 | 1.20 |
| Book NAV/Share(Rs) | 131.37 | 112.35 | 93.65 | 71.70 | 59.12 |
| Tax Rate(%) | 27.75 | 22.42 | 24.19 | 26.96 | 25.00 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 19.13 | 18.44 | 21.63 | 21.60 | 17.23 |
| EBIT Margin(%) | 15.17 | 14.27 | 20.04 | 20.09 | 14.63 |
| Pre Tax Margin(%) | 11.81 | 11.47 | 17.79 | 17.38 | 11.03 |
| PAT Margin (%) | 8.54 | 8.90 | 13.49 | 12.69 | 8.28 |
| Cash Profit Margin (%) | 13.28 | 13.33 | 17.15 | 16.78 | 12.59 |
| Performance Ratios | |||||
| ROA(%) | 7.50 | 8.35 | 13.82 | 10.99 | 7.43 |
| ROE(%) | 17.87 | 19.18 | 29.57 | 22.52 | 15.73 |
| ROCE(%) | 17.63 | 18.52 | 28.38 | 22.53 | 16.45 |
| Asset Turnover(x) | 0.88 | 0.94 | 1.02 | 0.87 | 0.90 |
| Sales/Fixed Asset(x) | 1.34 | 1.57 | 1.79 | 1.44 | 1.48 |
| Working Capital/Sales(x) | 11.50 | 13.92 | 7.45 | 5.67 | 6.05 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.75 | 0.64 | 0.56 | 0.69 | 0.68 |
| Receivable days | 64.28 | 62.51 | 69.17 | 85.61 | 77.03 |
| Inventory Days | 81.07 | 72.15 | 59.88 | 67.35 | 74.95 |
| Payable days | 106.11 | 104.51 | 131.01 | 110.49 | 93.97 |
| Valuation Parameters | |||||
| PER(x) | 45.46 | 27.75 | 34.25 | 21.13 | 6.77 |
| PCE(x) | 28.98 | 18.37 | 26.73 | 15.91 | 4.29 |
| Price/Book(x) | 7.47 | 4.84 | 8.87 | 4.32 | 0.95 |
| Yield(%) | 0.20 | 0.37 | 0.29 | 0.65 | 2.14 |
| EV/Net Sales(x) | 4.27 | 2.80 | 4.84 | 2.93 | 0.84 |
| EV/Core EBITDA(x) | 21.43 | 14.97 | 20.43 | 12.12 | 4.43 |
| EV/EBIT(x) | 28.13 | 19.63 | 24.17 | 14.59 | 5.73 |
| EV/CE(x) | 4.47 | 3.17 | 4.24 | 2.32 | 0.71 |
| M Cap / Sales | 3.85 | 2.45 | 4.58 | 2.67 | 0.54 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 15.13 | 22.73 | 56.24 | 12.12 | 9.79 |
| Core EBITDA Growth(%) | 22.55 | -3.16 | 53.18 | 43.10 | 17.56 |
| EBIT Growth(%) | 22.38 | -12.64 | 55.87 | 53.99 | 12.63 |
| PAT Growth(%) | 10.47 | -19.04 | 65.97 | 71.98 | 30.77 |
| EPS Growth(%) | 10.25 | -19.29 | 65.53 | 77.23 | 24.39 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.85 | 0.73 | 0.55 | 0.53 | 0.65 |
| Current Ratio(x) | 1.17 | 1.14 | 1.27 | 1.33 | 1.33 |
| Quick Ratio(x) | 0.68 | 0.72 | 0.84 | 1.00 | 0.90 |
| Interest Cover(x) | 4.52 | 5.09 | 8.88 | 7.41 | 4.07 |
| Total Debt/Mcap(x) | 0.11 | 0.15 | 0.06 | 0.12 | 0.68 |
Compare Financial Ratios of peers of CARYSIL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CARYSIL | ₹2,137.8 Cr | -1.6% | -2.6% | -7.1% | Stock Analytics | |
| HINDUSTAN UNILEVER | ₹556,877.0 Cr | 1.3% | -4.5% | -12.8% | Stock Analytics | |
| GODREJ CONSUMER PRODUCTS | ₹111,835.0 Cr | 2.3% | -11.1% | -4.6% | Stock Analytics | |
| DABUR INDIA | ₹90,972.9 Cr | 1.2% | -1.8% | -8.3% | Stock Analytics | |
| COLGATEPALMOLIVE (INDIA) | ₹75,598.4 Cr | 2% | -4% | 6.8% | Stock Analytics | |
| PROCTER & GAMBLE HYGIENE AND HEALTH CARE | ₹47,301.8 Cr | -0% | -8.4% | -15.6% | Stock Analytics | |
CARYSIL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CARYSIL | -1.6% |
-2.6% |
-7.1% |
| SENSEX | 1.9% |
-0.4% |
10.4% |
You may also like the below Video Courses
